Our in vitro data with A02 are in agreement with the literature reports on several malignant cell types, suggesting that PPARγ activation inhibits human carcinoma cell growth by regulating the expression of the cell cycle-associated proteins and inducing terminal differentiation [37,38,39,40]. The gene discussed is PPARG; the disease is carcinoma.